NuCana (NCNA) Change in Receivables (2017 - 2025)
NuCana's (NCNA) quarterly Change in Receivables came in at $2.8 million in Q4 2025, up 832.28% year-on-year from $304189.9 in Q4 2024, and up 210.04% quarter-over-quarter from -$2.6 million in Q3 2025.
NuCana (NCNA) Change in Receivables (2017 - 2025) Analysis & Trends
NuCana has disclosed Change in Receivables across 9 years of filings, most recently posting $2.8 million for Q4 2025.
- Change in Receivables for Q4 2025 came in at $2.8 million, up 832.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 million (up 25.47% YoY), and the FY2025 annual result was $143717.6, down 93.53% from the prior year.
- Change in Receivables came in at $2.8 million for Q4 2025 at NuCana, up from -$2.6 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $2.8 million in Q4 2025 to a low of -$2.6 million in Q3 2025.
- The 5-year median for Change in Receivables is $413752.9 (2022), against an average of $352249.8.
- Across the five-year window, Change in Receivables soared 1504.76% in 2023 and plunged 326.7% in 2025, its largest moves.
- NuCana's Change in Receivables stood at $859602.9 in 2021, then plunged by 113.92% to -$119634.8 in 2022, then surged by 829.33% to $872529.8 in 2023, then plunged by 65.14% to $304189.9 in 2024, then soared by 832.28% to $2.8 million in 2025.
- The last three Change in Receivables figures came in at $2.8 million (Q4 2025), -$2.6 million (Q3 2025), and $304189.9 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -4.08 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | 2.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.84 Mn |
| Dec 31, 2025 | 2.84 Mn |
| Sep 30, 2025 | -2.58 Mn |
| Sep 30, 2025 | -2.58 Mn |
| Dec 31, 2024 | 304,189.94 |
| Dec 31, 2024 | 304,189.94 |
| Sep 30, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Dec 31, 2023 | 872,529.78 |
| Dec 31, 2023 | 872,529.78 |
| Sep 30, 2023 | -958,880.39 |
| Sep 30, 2023 | -958,880.39 |
| Jun 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | -66,853.02 |
| Mar 31, 2023 | -66,853.02 |
| Jun 30, 2022 | -119,634.85 |
| Jun 30, 2022 | -119,634.85 |
| Mar 31, 2022 | 523,315.92 |
| Mar 31, 2022 | 523,315.92 |